Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial
Autor: | Petrylak, Daniel P, Vogelzang, Nicholas J, Budnik, Nikolay, Wiechno, Pawel Jan, Sternberg, Cora N, Doner, Kevin, Bellmunt, Joaquim, Burke, John M, de Olza, Maria Ochoa, Choudhury, Ananya, Gschwend, Juergen E, Kopyltsov, Evgeny, Flechon, Aude, Van As, Nicolas, Houede, Nadine, Barton, Debora, Fandi, Abderrahim, Jungnelius, Ulf, Li, Shaoyi, de Wit, Ronald, Fizazi, Karim |
---|---|
Zdroj: | In The Lancet Oncology April 2015 16(4):417-425 |
Databáze: | ScienceDirect |
Externí odkaz: |